Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Special immune cells called Regulatory T cells help control skin inflammation and repair in various skin diseases.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Pregnancy can cause specific skin conditions that need correct diagnosis and treatment to protect both mother and baby.

FOXN1 mutations can cause varying immune and physical issues, with severity influenced by gene activity and possibly other factors.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Double-stranded RNA causes inflammation in hair follicle cells, which may help understand and treat alopecia areata.

The WNT signaling pathway is crucial for mesenchymal stem cells' function and therapy success.

Mice with autoimmune hair loss showed signs of heart problems.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

Patients with severe alopecia areata have higher levels of MIF, which decrease after successful treatment.

The apelinergic system might protect the heart from damage caused by doxorubicin.

Curcumin may help reverse aging by targeting specific genes.

The mtDNA N haplogroup is linked to a higher risk of late-onset lupus and specific symptoms in Han Chinese women.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

Different types of fibroblasts play various roles in kidney repair and aging, and may affect chronic kidney disease outcomes.

People with first-time vitiligo have lower levels of a certain brain protein compared to healthy individuals.

Alopecia areata patients have lower zinc, copper, and selenium levels than healthy people.

Blocking interferon-gamma might help treat various autoimmune diseases.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

New treatments for diabetes, central nervous system repair, and cartilage injury were found, and a way to create functional hair follicles from stem cells was developed.

Chicken feather gene mutation helps understand human hair disorders.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Certain proteins involved in DNA modification may affect the genetic changes in systemic lupus erythematosus and could indicate the disease's activity.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.